Medical Economics February 9, 2024
Change takes effect in 2025 and could benefit more than one million Medicare beneficiaries
A provision in the Inflation Reduction Act will implement a $2000 out-of-pocket cap on Medicare beneficiaries’ prescription drug spending, which could save money for more than one million enrollees when it takes effect next year.
Starting in 2025, Medicare beneficiaries will have their out-of-pocket spending on Part D prescription drugs capped at $2,000, as specified in the Inflation Reduction Act of 2022 (IRA). According to a new KFF analysis, more than one million beneficiaries could benefit from this change.
Among the numerous drug-related provisions in the IRA is a change to ensure that Medicare beneficiaries pay no more than $2,000 out of pocket for prescription drugs...
Today's Sponsors
Today's Sponsor